What's driving Neurovascular embolization devices Market ; Eminent Players - Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A.
With significant presence of key players and high healthcare expenditure, North America is projected to be the dominant regional market for neurovascular embolization devices over the forecast period. Asia Pacific neurovascular embolization devices market is projected to grow at a CAGR of 5.2% due to growing awareness regarding brain aneurysms and other neurovascular diseases as well as significant presence of key manufacturers.
Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/25969
The report tracks some of the key companies operating in the neurovascular embolization devices market, including Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A., Terumo Corporation, and Johnson and Johnson Services, Inc.
The increasing awareness regarding neurovascular disease, and technological advancements in the diagnostic techniques are expected to propel the demand for neurovascular embolization devices over the forecast period. As per the latest research by the company, the global neurovascular embolization devices market is expected to account for more than US$ 1,733.1 Mn, in terms of value, by 2028 end. The report on neurovascular embolization devices market further projects significant growth potential with average year-on-year growth rate estimated at 4.4% through 2028. This elevation in the growth graph of neurovascular embolization devices market is attributed to increasing demand for minimally invasive neurosurgical procedure for better patient outcomes.
It is claimed by the Brain Aneurysm Foundation that around 6 million people in the U.S. suffer from brain aneurysms, which is expected to fuel the adoption minimally invasive neurovascular procedure. More than 500,000 people worldwide die due to stroke and other disorders associated with cerebral aneurysms, which is also increasing the demand for neurovascular embolization devices. Intracranial aneurysm is prevalent in individuals younger than 60 years, as half out of the total mortality rate due to brain aneurysms comprises share of young individuals below age 50.
It is been found by the Brain Aneurysm Foundation that about 15% of individuals possessing aneurysms in the neurovascular tract are very likely to have more than one aneurysm. This factor further increases the demand for neurovascular embolization devices from the individuals suffering from cerebral aneurysms. Neurovascular aneurysms if not treated can result in severe consequences of neurological defects and permanent impairment of cognitive functions in the absence of neurovascular embolization devices. The observations of these outcomes from brain aneurysms is also projected to fuel the demand for neurovascular embolization devices over the forecast period.
Request For Methodology @ https://www.persistencemarketresearch.com/methodology/25969
The company has segmented the global neurovascular embolization devices market based on product type, end user and region. In terms of revenue, the embolization devices product type segment of the neurovascular embolization devices market is expected to hold significant share and grow at a high CAGR of 4.9% in the global neurovascular embolization devices market over the forecast period.
Flow diversion stents segment in the neurovascular embolization devices market is also expected to grow at a significant CAGR owing to the low associated risks and their growing adoption by the end users. Aneurysm clips segment in the neurovascular embolization devices market is estimated to contribute 2.4% market share in the terms of revenue. These devices have witness significant decrease in demand due to invasive nature of the treatment.
Table of Contents
13. Competition Landscape
13.1. Competition Dashboard
13.2. Company Deep Dive
13.2.1. Medtronic plc
220.127.116.11. Product and End Users Portfolio
18.104.22.168. Production Footprint
22.214.171.124. Sales Footprint
126.96.36.199. Channel Footprint
188.8.131.52.1. Marketing Strategy
184.108.40.206.2. Product Strategy
220.127.116.11.3. Channel Strategy
13.2.2. Stryker Corporation
13.2.3. Terumo Corporation
13.2.4. Johnson & Johnson Services, Inc.
13.2.5. Penumbra Inc.
13.2.6. Balt Extrusion S.A
13.2.7. B. Braun Melsungen AG.
13.2.8. Integra LifeSciences Corporation
13.2.9. Resonetics Llc
13.2.10. Acandis GmbH
14. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028 By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region
14.2.1. North America
14.2.2. Latin America
14.2.5. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region
14.4. Market Attractiveness Analysis By Region
15. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028, By Product Type
15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
15.2.1. Embolization Coils
15.2.2. Liquid Embolic Systems
15.2.3. Flow Diversion Stents
15.2.4. Aneurysm Clips
15.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
15.4. Market Attractiveness Analysis By Product Type
Buy Now@ https://www.persistencemarketresearch.com/checkout/25969
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving Neurovascular embolization devices Market ; Eminent Players - Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A. here
News-ID: 1761771 • Views: 352
More Releases from persistencemarketresearch.com
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia
Ammonia Inhalants Market Analysis- Size, Share, overview, scope, Revenue, Gross …
Ammonia inhalants are respiratory stimulant because ammonia gas irritates the lungs and triggers an inhalation reflex. This reflex alters breathing patterns and results in improved flow rates of the respiratory system and possibly increase the alertness. Basically, it works by triggering reflexive action which causes the muscle that controls the breathing process to perform faster. Additional it acts as a sympathetic nervous system and enhances the activities of heart and brain.
More Releases for Neurovascular
Neurovascular Embolization Device Market: Competitive Dynamics & Global Outlook …
New report published by Market Research Report Store (MRRS) which offers insights on the global Neurovascular Embolization Device market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/242161/global-neurovascular-embolization-device-market Global Neurovascular Embolization Device Market: Forecast by Type / Application / Region According to this study, over the next five years the Neurovascular Embolization Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million
Global Neurovascular Devices Market: Rising Geriatric Population and Neurovascul …
Besides exponential rise in occurrences of critical neurovascular ailments such as ischemic stroke and aneurysm amongst others, burgeoning advances in product enhancements, improved reimbursements, and surged healthcare expenditure are accounted to etch growth in global neurovascular devices market in forthcoming years. These market highlights are in line with Market Research Hub's (MRH) recent research report titled, 'Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 - 2017) and
Neurovascular Devices Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Neurovascular Devices market. Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy
Future For Neurovascular Devices Market...By 2024
MaketStudyReport.com adds a New Neurovascular Devices Market Research Report for the period of 2018 - 2024 that shows the growth of the market for next few years along with providing a competitive landscape. Neurovascular Devices Market will reach USD 2.0 billion by 2024; as per a new research report. Increasing incidences and financial cost burden associated with neurological disorders such as acute ischemic stroke and brain aneurysm will drive neurovascular devices industry
Neurovascular Devices Market - Regional Outlook 2017 - 2025
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In recent years, advances in balloon- and stent- assisted coiling in endovascular therapies have expanded the options for surgeons and patients in the treatment of aneurysms. The rising morbidity and mortality
Neurovascular Devices Market Growth and Forecast-2026
Neurological devices/Interventional neurology is the non-surgical specialty that uses minimally invasive, image guided techniques for the treatment of most complex and dangerous diseases of neck, brain, and spine. The surgical procedure or specialty for the treatment of neurovascular diseases is called neurosurgery. Neurology is the medicine branch that deals with the disorders of the entire nervous system and brain. Interventional neurology deals with the treatment and diagnosis of all categories